• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

Drug Eluting Stents (DES) - Pipeline Review, 2015

  • ID: 3165403
  • March 2015
  • Region: Global
  • 233 Pages
  • GlobalData

This Medical Devices sector report, “Drug Eluting Stents (DES) - Pipeline Review, 2015"" provides an overview of Drug Eluting Stents currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key drug eluting stents pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by our team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope:

- Extensive coverage of the Drug Eluting Stents products under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major READ MORE >

Note: Product cover images may vary from those shown

Introduction
Drug Eluting Stents (DES) Overview
Products under Development
Drug Eluting Stents (DES) - Pipeline Products by Stage of Development
Drug Eluting Stents (DES) - Pipeline Products by Segment
Drug Eluting Stents (DES) - Pipeline Products by Territory
Drug Eluting Stents (DES) - Pipeline Products by Regulatory Path
Drug Eluting Stents (DES) - Pipeline Products by Estimated Approval Date
Drug Eluting Stents (DES) - Ongoing Clinical Trials
Drug Eluting Stents (DES) - Pipeline Products under Development by Companies
Drug Eluting Stents (DES) Companies - Pipeline Products by Stage of Development
Drug Eluting Stents (DES) - Pipeline Products by Stage of Development
Drug Eluting Stents (DES) Companies and Product Overview
Abbott Vascular Inc. Company Overview
Abbott Vascular Inc. Pipeline Products & Ongoing Clinical Trials Overview
Abbott Vascular Inc. - Ongoing Clinical Trials Overview
Absorb Bioresorbable Vascular Scaffold Clinical Trial Details
AlviMedica Medical Technologies Inc. Company Overview
AlviMedica Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview
AlviMedica Medical Technologies Inc. - Ongoing Clinical Trials Overview
Cre8 DES Clinical Trial Details
Amaranth Medical, Inc. Company Overview
Amaranth Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Amaranth Medical, Inc. - Ongoing Clinical Trials Overview
FORTITUDE Scaffold Ongoing Clinical Trial Details
Next Generation FORTITUDE Scaffold Ongoing Clinical Trial Details
Arterius Ltd Company Overview
Arterius Ltd Pipeline Products & Ongoing Clinical Trials Overview
Biosensors International Group, Ltd. Company Overview
Biosensors International Group, Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Biosensors International Group, Ltd. - Ongoing Clinical Trials Overview
BioFreedom Drug Coated Stent Clinical Trial Details
Excel II DES Ongoing Clinical Trial Details
BioSurfaces, Inc. Company Overview
BioSurfaces, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Biotronik SE & Co. KG Company Overview
Biotronik SE & Co. KG Pipeline Products & Ongoing Clinical Trials Overview
Biotronik SE & Co. KG - Ongoing Clinical Trials Overview
Orsiro Hybrid Drug Eluting Stent Clinical Trial Details
Boston Scientific Corporation Company Overview
Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview
Boston Scientific Corporation - Ongoing Clinical Trials Overview
SYNERGY Everolimus-Eluting Stent System Clinical Trial Details
CARDIONOVUM GmbH Company Overview
CARDIONOVUM GmbH Pipeline Products & Ongoing Clinical Trials Overview
CID S.r.l. Company Overview
CID S.r.l. Pipeline Products & Ongoing Clinical Trials Overview
Contego Medical, LLC Company Overview
Contego Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview
DISA Vascular (Pty) Ltd. Company Overview
DISA Vascular (Pty) Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Elixir Medical Corporation Company Overview
Elixir Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview
Elixir Medical Corporation - Ongoing Clinical Trials Overview
DESyne BD Novolimus Eluting Coronary Stent System Ongoing Clinical Trial Details
DESyne Nx Novolimus Eluting Coronary Stent System Ongoing Clinical Trial Details
DESolve Novolimus Eluting Bioresorbable Coronary Scaffold System Ongoing Clinical Trial Details
Envision Scientific Pvt. Ltd Company Overview
Envision Scientific Pvt. Ltd Pipeline Products & Ongoing Clinical Trials Overview
Eurocor GmbH Company Overview
Eurocor GmbH Pipeline Products & Ongoing Clinical Trials Overview
HangZhou HuaAn Biotechnology Co.,Ltd Company Overview
HangZhou HuaAn Biotechnology Co.,Ltd Pipeline Products & Ongoing Clinical Trials Overview
Icon Interventional Systems, Inc. Company Overview
Icon Interventional Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
ICON Medical Corp. Company Overview
ICON Medical Corp. Pipeline Products & Ongoing Clinical Trials Overview
InspireMD, Inc. Company Overview
InspireMD, Inc. Pipeline Products & Ongoing Clinical Trials Overview
IRAMED GmbH Company Overview
IRAMED GmbH Pipeline Products & Ongoing Clinical Trials Overview
Lepu Medical Technology (Beijing) Co., Ltd. Company Overview
Lepu Medical Technology (Beijing) Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Lepu Medical Technology (Beijing) Co., Ltd. - Ongoing Clinical Trials Overview
Nano+ Stent Ongoing Clinical Trial Details
Medinol Ltd. Company Overview
Medinol Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Medinol Ltd. - Ongoing Clinical Trials Overview
NIRsupreme Ridaforolimus-Eluting Coronary Stent System Clinical Trial Details
Medtronic plc Company Overview
Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
Meril Life Sciences Pvt. Ltd. Company Overview
Meril Life Sciences Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Meril Life Sciences Pvt. Ltd. - Ongoing Clinical Trials Overview
BioMime Ongoing Clinical Trial Details
Micell Technologies, Inc. Company Overview
Micell Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Minvasys Company Overview
Minvasys Pipeline Products & Ongoing Clinical Trials Overview
NanoCoeur, Inc. Company Overview
NanoCoeur, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Northwestern University Company Overview
Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
OrbusNeich Company Overview
OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview
OrbusNeich - Ongoing Clinical Trials Overview
COMBO Dual Therapy Stent Clinical Trial Details
REVA Medical, Inc. Company Overview
REVA Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Sino Medical-Device Technology Co., Ltd. Company Overview
Sino Medical-Device Technology Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Stentys, SA Company Overview
Stentys, SA Pipeline Products & Ongoing Clinical Trials Overview
Svelte Medical Systems, Inc. Company Overview
Svelte Medical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Tepha, Inc. Company Overview
Tepha, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Terumo Corporation Company Overview
Terumo Corporation Pipeline Products & Ongoing Clinical Trials Overview
Terumo Corporation - Ongoing Clinical Trials Overview
Ultimaster Ongoing Clinical Trial Details
Tryton Medical, Inc. Company Overview
Tryton Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
University of Strathclyde Company Overview
University of Strathclyde Pipeline Products & Ongoing Clinical Trials Overview
VasoTech Inc. Company Overview
VasoTech Inc. Pipeline Products & Ongoing Clinical Trials Overview
Xenogenics Corporation Company Overview
Xenogenics Corporation Pipeline Products & Ongoing Clinical Trials Overview
Zorion Medical Company Overview
Zorion Medical Pipeline Products & Ongoing Clinical Trials Overview
Drug Eluting Stents (DES)- Recent Developments
Mar 02, 2015: Tryton Medical Announces Publication of Data from Pivotal Trial for Tryton Side Branch Stent in Journal of American College of Cardiology
Feb 23, 2015: REVA Bioresorbable Program Update at CRT Conference
Feb 19, 2015: BIOTRONIK Advances Clinical Evaluation of Latest Generation DREAMS, World’s First Bioabsorbable Magnesium Scaffold
Feb 13, 2015: COMBO Dual Therapy Stent - Three-year Data featured at JIM 2015
Feb 12, 2015: Svelte Medical Systems and ASAHI INTECC Announce Manufacturing and Co-Branding Agreements
Feb 12, 2015: Biosensors Reports Financial Results for the Third Quarter of Fiscal Year 2015
Feb 09, 2015: LEADERS Free Japan Trial Completes Enrollment
Feb 04, 2015: Micell Technologies MiStent SES Now Commercially Available in Europe
Feb 04, 2015: BIOTRONIK Announces Completion of Patient Enrollment in BIOFLOW-IV Study Evaluating Safety and Efficacy of Orsiro
Jan 29, 2015: Abbott Reports Fourth-Quarter 2014 Results
Jan 23, 2015: MicroPort Receives CE Mark Approval for Firehawk
Jan 20, 2015: Mr. Aurelio Sahagun Promoted to COO of MicroPort Orthopedics
Jan 16, 2015: Eurocor Receives CE Mark Approval for E-Magic Plus SES
Jan 06, 2015: Biosensors Announces CTO’S Retirement
Jan 05, 2015: Acacia Subsidiary Enters into Settlement and Patent License Agreement with Cordis
Jan 04, 2015: Firehawk Gains CFDA Approval to Offer More Specifications
Dec 11, 2014: COMBO Dual Therapy Stent Healing Benefits Highlighted at GulfPCR-GIM 2014
Dec 03, 2014: REVA Implants First Patients With Fantom Scaffold
Dec 02, 2014: Terumo receives CE Mark approval for the line extension on Drug-eluting Stent, Ultimaster to advance the treatment of coronary artery disease
Nov 19, 2014: New Data From EVOLVE Clinical Program Demonstrate SYNERGY Bioabsorbable Polymer Stent Meets Key Performance Endpoints
Nov 12, 2014: Biosensors Reports Financial Results for the Second Quarter and First Half of Fiscal Year 2015
Nov 05, 2014: ClearStream Technologies Expands Enniscorthy Facility
Nov 04, 2014: Boston Scientific To Host And Webcast Investor Event
Nov 03, 2014: Micell Technologies Announces Plans for MiStent SES Commercial Launch
Nov 03, 2014: Medtronic Secures CE Mark For Resolute Onyx Drug-eluting Stent
Nov 03, 2014: STENTYS Expands Product Offering To All Coronary Stent Indications Through Exclusive Agreement With Micell To Distribute Its Novel Drug-Eluting Stent
Oct 27, 2014: STENTYS’ Sirolimus-Eluting Stent Receives CE Marking
Oct 20, 2014: Boston Scientific Initiates Study Of Promus PREMIER Coronary Stent System In Underserved Patient Populations
Oct 17, 2014: COMBO Dual Therapy Stent - A Long-term Solution to Vessel Restoration
Oct 10, 2014: BIOTRONIK to Offer New Treatment Options in France with Release of Orsiro Drug-Eluting Stent
Sep 18, 2014: Latest Data Shows OrbusNeich's COMBO Dual Therapy Stent has Excellent Healing Benefits
Sep 18, 2014: World’s First Integrated Delivery System Meets All Endpoints in the Direct II Randomized, Controlled Drug-Eluting Coronary Stent Study
Sep 16, 2014: REVA Presents Fantom Scaffold Program at TCT 2014 Conference
Sep 16, 2014: Micell Technologies Highlights Positive Three-Year Data from MiStent SES DESSOLVE Clinical Studies at TCT 2014
Sep 16, 2014: Amaranth Medical Initiates Clinical Trial of the Second-Generation FORTITUDE Bioresorbable Drug-Eluting Scaffold
Sep 15, 2014: Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart Device
Sep 14, 2014: ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent
Sep 10, 2014: Tryton Medical Enrolls First U.S. Patient in the EXTENDED ACCESS Registry
Sep 10, 2014: Global Bifurcation Leader Tryton Medical Announces Events at TCT 2014
Sep 08, 2014: Elixir Medical Announces Schedule of Programs for TCT 2014
Sep 04, 2014: Initial Patient Enrolled in BioFreedom USA: First Major American Trial for Biosensors
Sep 03, 2014: STENTYS Reaches 10,000 Self-Apposing Stent implantations
Sep 01, 2014: BIOSCIENCE Trial Further Confirms Orsiro as Best in Class
Sep 01, 2014: Biosensors Welcomes New CEO
Aug 06, 2014: Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2015
Jul 28, 2014: Tryton Medical Enrolls First Patient in the EXTENDED Access Registry
Jul 16, 2014: First patient enrollment in MASCOT registry represents major milestone for COMBO Dual Therapy Stent and OrbusNeich's clinical program
Jul 10, 2014: Abbott Builds Long Term Commitment In China
Jul 09, 2014: Micell Technologies Adds to Portfolio of Intellectual Property Protection
Jul 09, 2014: STENTYS Expands Marketing of the Self-Apposing Stent in South America
Jun 24, 2014: Abbott Announces Job Reductions At Lake County Headquarters In US
Jun 17, 2014: Biosensors Leaders Free Japan Trial Enrolls First Patient
Jun 12, 2014: First Patient Enrolled in Investigator Initiated REDUCE Study
Jun 02, 2014: Stentys Completes Acquisition of Cappella Peel Away from Cappella for USD1.4 Million
May 29, 2014: Svelte Medical Systems Announces Completion of 6-Month Follow-up in the DIRECT II Drug-Eluting Stent Study
May 28, 2014: Biosensors Reports Financial Results for Fiscal Year 2014
May 28, 2014: Biosensors Announces Appointment of New CEO
May 27, 2014: STENTYS Self-Apposing Stent Featured Prominently at 2014 EuroPCR Conference
May 23, 2014: OrbusNeich Releases Long-term Data for World's First and Only Dual Therapy Stent
May 23, 2014: Micell Technologies Announces Positive Long-Term Data from MiStent SES Clinical Studies Presented at EuroPCR 2014
May 23, 2014: Elixir Medical Announces Clinical Trial Results of DESyne BD Novolimus Eluting Coronary Stent System at EuroPCR
May 23, 2014: Elixir Medical Announces Results for CE mark-approved DESolve Novolimus Eluting Bioresorbable Coronary Scaffold System at EuroPCR
May 23, 2014: Elixir Medical Announces Outstanding Long-Term Clinical Results at EuroPCR for World’s Broadest Portfolio of Three CE Mark-Approved Novolimus Eluting Coronary Intervention Systems
May 22, 2014: REVA Holds Sponsored Symposium at EuroPCR
May 22, 2014: Complex Lesion BIOFLOW-III Subgroup Analyses Further Support Top Performance of BIOTRONIK Orsiro
May 21, 2014: Successful Live Case Demonstration of Elixir Medical’s CE Mark-Approved Fully Bioresorbable DESolve 100 Novolimus Eluting Coronary Scaffold System at EuroPCR
May 21, 2014: Boston Scientific Reports Strong Performance Data For SYNERGY Stent System
May 21, 2014: Biosensors Leaders Free Patient Population Data Presented at EuroPCR Enrollment Now Complete
May 21, 2014: Small Vessel BIOFLOW-II Subgroup Analyses Demonstrate Top Performance of BIOTRONIK Orsiro
May 20, 2014: STENTYS Sirolimus-Eluting Stent Demonstrates Best in Class Efficacy for Heart Attack Patients
May 15, 2014: Micell Technologies Announces Clinical Data from MiStent SES Studies Will Be Presented at EuroPCR 2014
May 14, 2014: Elixir Medical to Showcase a Live Case Demonstration of the Breakthrough Fully Bioresorbable DESolve 100 Novolimus Eluting Coronary Scaffold System at EuroPCR
May 13, 2014: Elixir Medical's DESolve 100 Novolimus Eluting Coronary Scaffold System Gets CE Mark
May 06, 2014: STENTYS: Journal of the American College of Cardiology Publication Shows Malapposition Influences Death from Early Stent Thrombosis
May 05, 2014: USFDA Grants IDE Approval For Biosensors’ BioFreedom US Feasibility Trial
May 01, 2014: Boston Scientific Launches Promus PREMIER Everolimus-Eluting Platinum Chromium Coronary Stent System In Japan
Apr 29, 2014: STENTYS’ Self-Apposing Stent Featured in New Article Published by the Journal of the American College of Cardiology
Apr 28, 2014: MicroPort Released New Products to its Nationwide Distributors
Apr 10, 2014: Abbott Completes Enrollment of Absorb Randomized Clinical Trials in the United States, Japan and China
Mar 28, 2014: Patient Enrollment Completed in Multicenter European REMEDEE Registry of OrbusNeich's COMBO Dual Therapy Stent
Mar 27, 2014: Arterial Remodeling Technologies Enters Into Co-Development Agreement With Terumo For Bioresorbable Scaffold
Appendix
Methodology
Keywords:
About the Publisher
Contact Us
Disclaimer

List of Tables
Drug Eluting Stents (DES) - Pipeline Products by Stage of Development
Drug Eluting Stents (DES) - Pipeline Products by Segment
Drug Eluting Stents (DES) - Pipeline Products by Territory
Drug Eluting Stents (DES) - Pipeline Products by Regulatory Path
Drug Eluting Stents (DES) - Pipeline Products by Estimated Approval Date
Drug Eluting Stents (DES) - Ongoing Clinical Trials
Drug Eluting Stents (DES) Companies - Pipeline Products by Stage of Development
Drug Eluting Stents (DES) - Pipeline Products by Stage of Development
Abbott Vascular Inc. Pipeline Products & Ongoing Clinical Trials Overview
Absorb Bioresorbable Vascular Scaffold - Product Status
Absorb Bioresorbable Vascular Scaffold - Product Description
XIENCE Thinman DES - Product Status
XIENCE Thinman DES - Product Description
Abbott Vascular Inc. - Ongoing Clinical Trials Overview
Absorb Bioresorbable Vascular Scaffold - A Clinical Evaluation of Absorb BVS, the Bioresorbable Vascular Scaffold, in the Treatment of Subjects With de Novo Native Coronary Artery Lesions in Chinese Population
Absorb Bioresorbable Vascular Scaffold - A Clinical Evaluation of Absorb BVS, The Everolimus Eluting Bioresorbable Vascular Scaffold In The Treatment Of Subjects With De Novo Native Coronary Artery Lesions
Absorb Bioresorbable Vascular Scaffold - A Clinical Evaluation of Absorb BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects with de Novo Native Coronary Artery Lesions
Absorb Bioresorbable Vascular Scaffold - A Clinical Evaluation of AVJ-301 (Absorb BVS), The Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions in Japanese Population
Absorb Bioresorbable Vascular Scaffold - A Clinical Evaluation to Compare the Safety, Efficacy and Performance of ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold System Against XIENCE Everolimus Eluting Coronary Stent System in the Treatment of Subjects with Ischemic Heart Disease Caused by de Novo Native Coronary Artery Lesions: ABSORB II Randomized Controlled Trial
Absorb Bioresorbable Vascular Scaffold - A Continuation in the Clinical Evaluation of the Abbott Vascular Everolimus-Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions: ABSORB EXTEND Clinical Investigation
Absorb Bioresorbable Vascular Scaffold - A Multicentre Prospective Natural History Study Using Multimodality Imaging in Patients with Acute Coronary Syndromes - PROSPECT II (Natural History Study) Combined with a Randomized, Controlled, Intervention Study - PROSPECT ABSORB (Randomized Trial)
Absorb Bioresorbable Vascular Scaffold - A Post-market Registry of Patients with de Novo Lesions in Previously Untreated Vessels Treated with Absorb BVS
Absorb Bioresorbable Vascular Scaffold - Amsterdam Investigator-initiated Absorb Strategy All-comers Trial (AIDA Trial): A Clinical Evaluation Comparing the Efficacy and Performance of ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold Strategy Versus the XIENCE Family (XIENCE PRIME or XIENCE Xpedition) Everolimus Eluting Coronary Stent Strategy in the Treatment of Coronary Lesions in Consecutive All-comers
Absorb Bioresorbable Vascular Scaffold - An International Post-market Registry of Patients With de Novo Lesions in Previously Untreated Vessels Treated With Absorb Bioresorbable Vascular Scaffold (Absorb BVS): ABSORB FIRST Registry
Absorb Bioresorbable Vascular Scaffold - Comparison of the ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold System With a Drug- Eluting Metal Stent (Xience) in Acute ST-Elevation Myocardial Infarction
Absorb Bioresorbable Vascular Scaffold - Comprehensive Imaging and Interventional Therapy Studies for Arteriogenic Erectile Dysfunction and Lower Urinary Tract Symptoms: a Multi-modality, Multi-specialty Collaborative Study (PERFECT Program)
Absorb Bioresorbable Vascular Scaffold - Everolimus-eluting Bioresorbable Vascular Scaffold System in the Treatment of Cardiac Allograft Vasculopathy in Heart Transplant Recipients: A Prospective Multicenter Pilot Study
Absorb Bioresorbable Vascular Scaffold - German-Austrian Register to Evaluate the Short and Long-term Safety and Therapy Outcomes of the ABSORB Everolimus-Eluting Bioresorbable Vascular Scaffold System in Patients With Coronary Artery Stenosis
Absorb Bioresorbable Vascular Scaffold - Impact of Vascular Reparative Therapy on Vasomotor Function and Myocardial Perfusion: A Randomized H215O PET/CT Study
Absorb Bioresorbable Vascular Scaffold - Intracoronary Scaffold Assessment a Randomised Evaluation of Absorb in Myocardial Infarction (ISAR-Absorb MI): A Prospective, Randomized Trial of BVS Veruss EES in Patients Undergoing Coronary Stenting for Myocardial Infarction
Absorb Bioresorbable Vascular Scaffold - Performance of Bioresorbable Scaffold in Primary Percutaneous Intervention of ST Elevation Myocardial Infarct (BVS in STEMI)
AlviMedica Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview
Coracto Rapamycin-Eluting Coronary Stent - Product Status
Coracto Rapamycin-Eluting Coronary Stent - Product Description
Cre8 DES - Product Status
Cre8 DES - Product Description
AlviMedica Medical Technologies Inc. - Ongoing Clinical Trials Overview
Cre8 DES - A Prospective, Multi-center, Randomized Controlled Trial Evaluating the Safety and Efficacy of the CRE8 Sirolimus-Eluting Stent Versus the RESOLUTE Zotarolimus-eluting Stent in the Treatment of Patients with De Novo Coronary Artery Lesions
Cre8 DES - A Prospective, Multi-center, Single-arm Observational Registry Trial Evaluating the Safety and Efficacy of CRE8 Sirolimus-Eluting Stent in the Treatment of Patients With De Novo Coronary Artery Lesions
Cre8 DES - A Prospective, Single Center, Open Label, Randomized Controlled, Two Arm Study Evaluating Safety and Efficacy of the Permanent Polymer Zotarolimus Eluting Stent Resolute Integrity Compared to the Polymer Free Amphilimus Eluting Stent Cre8
Amaranth Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
FORTITUDE Scaffold - Product Status
FORTITUDE Scaffold - Product Description
Next Generation FORTITUDE Scaffold - Product Status
Next Generation FORTITUDE Scaffold - Product Description
Amaranth Medical, Inc. - Ongoing Clinical Trials Overview
FORTITUDE Scaffold - Restoring Endoluminal Narrowing Using Bioresorbable Scaffolds - European Trial
Next Generation FORTITUDE Scaffold - Amaranth Endovascular Study of a Drug-eluting Bioresorbable Coronary Scaffold
Arterius Ltd Pipeline Products & Ongoing Clinical Trials Overview
Arteriosorb Absorbable Drug-Eluting Scaffold - Product Status
Arteriosorb Absorbable Drug-Eluting Scaffold - Product Description
Biosensors International Group, Ltd. Pipeline Products & Ongoing Clinical Trials Overview
BioFreedom Drug Coated Stent - Product Status
BioFreedom Drug Coated Stent - Product Description
Excel II DES - Product Status
Excel II DES - Product Description
Biosensors International Group, Ltd. - Ongoing Clinical Trials Overview
BioFreedom Drug Coated Stent - A Prospective Randomized Comparison of the BioFreedom Biolimus A9 Drug Coated Stent versus the Gazelle Bare Metal Stent in Patients with High Risk of Bleeding
BioFreedom Drug Coated Stent - To Collect Additional Safety and Effectiveness Data for the Biosensors BioFreedom BA9 Drug Coated Coronary Stent in Patients with Native, de Novo Coronary Artery Disease
Excel II DES - A Prospective Multicenter Randomized Trial to Assess the Safety and Effectiveness of EXCEL-II Sirolimus Eluting Stent vs. EXCEL Sirolimus Eluting Stent for the Treatment of Patients with de Novo Coronary Artery Lesions (CREDIT II Trial)
BioSurfaces, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Drug-Eluting Stent Jacket - Product Status
Drug-Eluting Stent Jacket - Product Description
Biotronik SE & Co. KG Pipeline Products & Ongoing Clinical Trials Overview
DREAMS - Product Status
DREAMS - Product Description
DREAMS 2 - Product Status
DREAMS 2 - Product Description
Orsiro Hybrid Drug Eluting Stent - Product Status
Orsiro Hybrid Drug Eluting Stent - Product Description
Biotronik SE & Co. KG - Ongoing Clinical Trials Overview
Orsiro Hybrid Drug Eluting Stent - BIOTRONIK - Safety and Performance Registry for an All-comers Patient Population with the Limus Eluting Orsiro Stent System Within Daily Clinical Practice - III French Satellite
Orsiro Hybrid Drug Eluting Stent - BIOTRONIK - SaFety and Performance Registry for an All-comers Patient Population With the Limus Eluting Orsiro Stent System Within Daily Clinical Practice - III United Kingdom Satellite
Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview
Next Generation SYNERGY - Product Status
Next Generation SYNERGY - Product Description
SYNERGY Everolimus-Eluting Stent System - Product Status
SYNERGY Everolimus-Eluting Stent System - Product Description
Boston Scientific Corporation - Ongoing Clinical Trials Overview
SYNERGY Everolimus-Eluting Stent System - A Prospective Optical Coherence Tomography (OCT) Study on Coronary Vessel Wall Response to Stent Eluting Everolimus from a Biodegradable Polymer (EES SYNERGY) Compared with Stent Eluting Zotarolimus from a Durable Polymer (ZES, RESOLUTE Integrity)
SYNERGY Everolimus-Eluting Stent System - A Single-Arm Trial to Evaluate the Effectiveness of PCI of de Novo 3-vessel Disease Applying the SYNTAX Score II With Pressure Wire Functional Assessment and IVUS Guidance, Using an Everolimus-eluting Stent With Biodegradable Abluminal Coating
SYNERGY Everolimus-Eluting Stent System - Comparison of Titanium-Nitride-Oxide Coated Bio-Active-Stent (Optimax) to the Drug (Everolimus) -Eluting Stent (Synergy) in Acute Coronary Syndrome
SYNERGY Everolimus-Eluting Stent System - Conventional Antegrade Vs Sub-intimal Synergy Stenting in Chronic Total Occlusions
SYNERGY Everolimus-Eluting Stent System - Improved Drug Eluting Stent for Percutaneous Coronary Intervention of the Left Main Artery in a Real World All-comers Population
SYNERGY Everolimus-Eluting Stent System - Randomized Clinical Comparison of Everolimus-eluting SYNERGY and Biolimus-eluting BioMatrix NeoFlex Coronary Stents in Non-selected Patients with Ischemic Heart Disease
SYNERGY Everolimus-Eluting Stent System - Randomized Comparison of the Biolimus-eluting Biomatrix Neoflex og Everolimus-eluting SYNERGY Stents in All-comer Patients with Ischemic Heart Disease: The OCT SORT-OUT VIII
CARDIONOVUM GmbH Pipeline Products & Ongoing Clinical Trials Overview
ReNATURAL (M) - Product Status
ReNATURAL (M) - Product Description
ReNATURAL (P) - Product Status
ReNATURAL (P) - Product Description
CID S.r.l. Pipeline Products & Ongoing Clinical Trials Overview
Janus Flex - Product Status
Janus Flex - Product Description
Optima Jet - Product Status
Optima Jet - Product Description
Contego Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview
CORGUARD - Product Status
CORGUARD - Product Description
DISA Vascular (Pty) Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Stellium Stent - Product Status
Stellium Stent - Product Description
Elixir Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview
DESolve 100 Novolimus Eluting Bioresorbable Coronary Scaffold System - Product Status
DESolve 100 Novolimus Eluting Bioresorbable Coronary Scaffold System - Product Description
DESolve Myolimus Eluting Bioresorbable Coronary Scaffold System - Product Status
DESolve Myolimus Eluting Bioresorbable Coronary Scaffold System - Product Description
DESolve Novolimus Eluting Bioresorbable Coronary Scaffold System - Product Status
DESolve Novolimus Eluting Bioresorbable Coronary Scaffold System - Product Description
DESyne BD Novolimus Eluting Coronary Stent System - Product Status
DESyne BD Novolimus Eluting Coronary Stent System - Product Description
DESyne Nx Novolimus Eluting Coronary Stent System - Product Status
DESyne Nx Novolimus Eluting Coronary Stent System - Product Description
Myolimus Eluting Coronary Stent - Durable Polymer - Product Status
Myolimus Eluting Coronary Stent - Durable Polymer - Product Description
Elixir Medical Corporation - Ongoing Clinical Trials Overview
DESyne BD Novolimus Eluting Coronary Stent System - Post Marketing Study of the Elixir Desyne Novolimus Eluting Coronary Stent System and the Desyne BD Novolimus Eluting Coronary Stent System in the Treatment of Patients with De Novo Native Coronary Artery Lesions
DESyne Nx Novolimus Eluting Coronary Stent System - Evaluation of the Novolimus-Eluting Coronary Stent System: A Randomized Study
DESolve Novolimus Eluting Bioresorbable Coronary Scaffold System - Post-market Evaluation of Desolve Novolimus Eluting Bioresorbable Coronary Scaffold System in the Treatment of Patients with De Novo Native Coronary Artery Lesions
Envision Scientific Pvt. Ltd Pipeline Products & Ongoing Clinical Trials Overview
FOCUS np - Product Status
FOCUS np - Product Description
Eurocor GmbH Pipeline Products & Ongoing Clinical Trials Overview
Genius TAXCOR - Product Status
Genius TAXCOR - Product Description
HangZhou HuaAn Biotechnology Co.,Ltd Pipeline Products & Ongoing Clinical Trials Overview
Xinsorb BRS - Product Status
Xinsorb BRS - Product Description
Icon Interventional Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Biosorb - Product Status
Biosorb - Product Description
ICON Medical Corp. Pipeline Products & Ongoing Clinical Trials Overview
Nuloy DES - Product Status
Nuloy DES - Product Description
InspireMD, Inc. Pipeline Products & Ongoing Clinical Trials Overview
MGuard Drug Eluting Stent - Product Status
MGuard Drug Eluting Stent - Product Description
IRAMED GmbH Pipeline Products & Ongoing Clinical Trials Overview
EasyRap - Product Status
EasyRap - Product Description
FlexyRap - Product Status
FlexyRap - Product Description
MovyTax - Product Status
MovyTax - Product Description
Lepu Medical Technology (Beijing) Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Nano+ Stent - Product Status
Nano+ Stent - Product Description
Lepu Medical Technology (Beijing) Co., Ltd. - Ongoing Clinical Trials Overview
Nano+ Stent - Efficacy and Safety of Nano+ Polymer-free Sirolimus-Eluting Stent in the Treatment of Patients With De Novo Lesion: A Optical Coherent Tomography Prospective, Multicenter Study
Medinol Ltd. Pipeline Products & Ongoing Clinical Trials Overview
NIRsupreme Ridaforolimus-Eluting Coronary Stent System - Product Status
NIRsupreme Ridaforolimus-Eluting Coronary Stent System - Product Description
Medinol Ltd. - Ongoing Clinical Trials Overview
NIRsupreme Ridaforolimus-Eluting Coronary Stent System - BioNIR Ridaforolimus Eluting Coronary Stent System (BioNIR) EUropean Angiography Study
NIRsupreme Ridaforolimus-Eluting Coronary Stent System - BioNIR Ridaforolimus Eluting Coronary Stent System (BioNIR) in Coronary Stenosis Trial
Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
Next Generation Coronary Stent - Product Status
Next Generation Coronary Stent - Product Description
Resolute Onyx - Product Status
Resolute Onyx - Product Description
Meril Life Sciences Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview
BioMime - Product Status
BioMime - Product Description
BIOMIME AURA - Product Status
BIOMIME AURA - Product Description
MeRes - Product Status
MeRes - Product Description
MITSU - Product Status
MITSU - Product Description
Meril Life Sciences Pvt. Ltd. - Ongoing Clinical Trials Overview
BioMime - A Prospective, Active Control Open Label, Multicentre Randomized Clinical Trial for Comparison Between BioMime Sirolimus Eluting Stent of and Xience Everolimus Eluting Stent to Evaluate Efficacy and Safety in Coronary Artery Disease
Micell Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
MiStent Sirolimus Eluting Coronary Stent System - Product Status
MiStent Sirolimus Eluting Coronary Stent System - Product Description
Minvasys Pipeline Products & Ongoing Clinical Trials Overview
Nile LM SIR Sirolimus Eluting Intracoronary Stent - Product Status

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Biotronik SE & Co.KG Woermannkehre OptiMed Medizinische Instrumente GmbH Medtronic, Inc. MicroVention, Inc. Raumedic AG